Urine Drug Testing: Current Recommendations and Best Practices (PDF - .26 MB)
Describes best practices of routine urine drug testing as part of an overall treatment plan that includes chronic opioid prescribing.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Describes best practices of routine urine drug testing as part of an overall treatment plan that includes chronic opioid prescribing.
Assesses a person's belief of "being in control" in situations involving drug abuse. Consists of 16-item pairs presented in a forced-choice format.
This worksheet is for primary care staff to help plan a quality improvement (QI) Plan-Do-Study-Act (PDSA) cycle, outlining the QI goals and how the practice will try to reach them, as well as providing space for actual outcomes and analysis of next steps.
Describes what SBIRT is, how SBIRT services are covered by Medicare, and what types of healthcare providers may provide SBIRT services under Medicare. These include physicians, physician assistants, nurse practitioners, clinical nurse specialists, clinical psychologists, and clinical social workers.
Gives families and friends information about MAT for opioid addiction. Describes prescribed opioid medications, their proper use and side effects, withdrawal symptoms, and ways medications fit with counseling in the recovery process.
The purpose of this manual is to introduce the ASSIST and to describe how to use it in health care settings – particularly community based primary health care settings – to identify people who are using substances, so that a brief intervention (or referral) can be provided, as appropriate.
Highlights the findings of the NIDA Clinical Trials Network study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. Examines opioid use, treatment with buprenorphine, and further implications for young adults with opioid addiction.
Provides information about the interactions of clinical significance that occur between buprenorphine or methadone and other medications.